WAS THE FDA MISLEAD ABOUT THE ANTIPSYCHOTIC DRUG ZYPREXA?
The Food and Drug Administration (FDA) is examining whether Eli Lilly & Company provided it with accurate data about the side effects of the antipsychotic drug Zyprexa, a potent medicine that has been linked to weight gain and diabetes. The FDA has questions about a Lilly document from February 2000 in which the company found…
read more